Connection

Makoto Ohtake to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Makoto Ohtake has written about Radiopharmaceuticals.
Makoto Ohtake
Connection Strength
0.027
Radiopharmaceuticals
  1. (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET. AJNR Am J Neuroradiol. 2014 Feb; 35(2):278-84.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.